June 7, 2024

How does this protect patients?

In comments submitted earlier this week, APC took issue with provisions of proposed new compounding regulations from the California Board of Pharmacy.

“We have serious concerns about the Board’s proposed regulations and the ongoing failure of the Board to root its regulation and enforcement of compounding in applicable law and science,” the letter states.

In addition to a cover letter enunciating five broad concerns about the Board’s proposal and its oversight of compounding in general, APC submitted detailed comments on specific provisions of the proposal. 

During the board’s public hearing on June 18, 2024, APC’s Tenille Davis will present the association’s concerns. Members and licensees in the state of California are urged to register to attend either virtually or in person. Details here.